Strong operations hide a ₹156 Cr loss—and a question about international demand
Headline numbers (28% revenue, 41% EBITDA growth, margin expansion to 41%) are genuine. But the reported PAT of ₹48.8 Cr buries a ₹156 Cr loss from the Dubai JV. Strip it out, and core operating profit was nearly 4x higher—and the real test is whether international demand fully recovers by peak season.
₹48.8 Cr
+460% YoY
₹156 Cr
masks core ops
~₹205 Cr
ex-JV headwind
₹143.4 Cr
+41% YoY, 41% margin
67.5%
vs 63.6% PY, tracking low-70s target
17%
ADR +10%, occupancy +4pp
Where the profit really sits
The reported PAT of ₹48.8 Cr (+460% YoY) looks extraordinary on the surface. But it is weighed down by a ₹156 Cr loss from the Dubai hotel JV (Leela owns 25%, equity-accounted). This loss is temporary. The asset is operationally break-even, and Leela is taking it over in CY27 for a 12-month renovation and rebrand. Strip it out, and core operating profit from owned and managed hotels was ~₹205 Cr—a far more powerful picture of what the quarter actually delivered. The reported number tells you the damage; the adjusted number tells you the strength.
While the Dubai hotel continues to be operational, reduced travel flows due to the West Asia conflict have impacted both occupancy and ADR for the time being. However, the asset is operationally break-even despite this being an off-peak period.
The operational print is solid
28% operating revenue growth
₹352 Cr revenue, 28.1% YoY
Supported ✓
41% EBITDA growth with 41% EBITDA margin
₹143.4 Cr EBITDA, ~41% growth and margin achieved
Supported ✓
67.5% occupancy vs 63.6% prior year
Occupancy recovered to 67.5%, 4pp improvement YoY
Supported ✓
Domestic room revenue +25%, international recovered to +1% by June
Domestic confirmed +25% YoY; intl -10% March → +1% June
Supported (but intl recovery incomplete) ⚠
Double-digit RevPAR growth and mid-to-high teens EBITDA growth FY27
Dependent on full international normalization; intl at +1% YoY vs -10% two years ago
Overstated—hinges on external recovery
The international recovery question
This is where the quarter reveals its dependency. International room revenue recovered from -10% YoY in March to +1% by June, but it remains a headwind. Before the geopolitical disruption, international represented roughly 50% of the revenue mix; it is now 30%. That shift carries material margin and growth implications. Management is confident that the Oct–Mar peak season will show "full recovery," but confidence and confirmation are different things. The FY27 guidance for double-digit RevPAR growth and mid-to-high teens EBITDA growth hinges on this recovery holding.
Management's tone on the call was measured. They reiterated guidance rather than raising it. They acknowledged March weakness and June recovery, and framed both as transient. But they did not promise a return to the 50-50 mix; they said domestic and international "can grow together." This is a credible hedge, not a bold prediction. The market rightly interprets it as: execution has been world-class; demand recovery will be the test.
What changed on this call
Three tangible shifts from the prior quarter:
International momentum visible (March -10% → June +1%). Trend reversing faster than feared; Oct–Mar peak season will confirm or refute full recovery.
Domestic segment confirmed as structural, not cyclical. Room revenue +25%, multi-generational travel rising, length-of-stay extending. Management reinvested in Kids Clubs, wellness, F&B to capture it.
Direct booking distribution doubled (16% vs 8% prior year). Website cost ~1/3 of OTA; margin benefit already embedded in 41% EBITDA.
How the street is positioned
The stock rallied hard post-result: +1.46% day 1, +1.55% day 3, +4.73% by day 5. The market's own verdict: the print was strong enough to justify a move, and the day-5 level suggests it held. The stock is now at ₹510.05, trading above its 20-day, 50-day, and 200-day simple moving averages (₹493.91, ₹479.06, ₹437.28 respectively), sitting 32.65% above its 52-week low but 3.22% below its all-time high. This is a stock that has climbed; the question is whether it has room to run.
Ownership flow tells a more nuanced story. FII ownership fell 75 bps quarter-on-quarter (from 8.62% to 7.87%), while DII ownership rose 101 bps (from 10.51% to 11.52%). The direction matters: foreign institutions took some profits post-rally; domestic institutions bought. This is consistent with a "good but not transformational" earnings print. Promoters remain steady at 75.91%.
The bull-bear ledger
Operational execution is world-class: 28% revenue, 41% EBITDA growth, 383 bps margin expansion, occupancy +4pp. Same-store hotels consistently hit/exceeded targets over 4+ quarters.
Domestic demand is structural, not cyclical. +25% room revenue backed by rising HNI base, multi-generational travel, and Leela's own investments. Repeatable.
Pricing power is real. Brand ranked #2 globally (5th time since 2020), NPS 86, iconic locations, RevPAR outperformance 1.4x luxury sector growth over 6 years. Defensible moat.
Direct bookings doubled; cost 1/3 of OTA. Distribution advantage embedded in current economics, not future upside.
FY30 ₹2,000 Cr EBITDA target (10x FY20) is concrete. Backed by 1,000+ key pipeline with proven 1.4x luxury-segment RevPAR outperformance. Not aspirational.
International recovery is only +1% YoY as of June. Down from -10% in March, but 30% of mix vs prior 50%. If peak season does not show full recovery, FY27 guidance (double-digit RevPAR, mid-high teens EBITDA) will miss.
QoQ decline is sharp: revenue -27%, PAT -71%. This is seasonal (Q1 is trough for luxury hotels), not a quality issue. But it raises quarterly visibility risk.
Dubai JV is temporary, but 25% ownership is material. ₹156 Cr loss in one quarter is manageable; the asset will drag until stabilized post-rebranding (CY27 rehab, CY28 ramp).
Leverage at 1.6x is comfortable, but management willing to 2.5x for value-accretive M&A. If growth disappoints (intl stays weak), leverage becomes binding.
Occupancy upside capped. City hotels at 72%, resorts ~60%; management targeting ADR, not occupancy >75%. If occupancy plateaus and ADR growth slows, RevPAR growth becomes harder.
Risks, ranked by how much they should concern a holder
International demand does not normalize fully by peak season (Oct–Mar FY27)
HighFY27 double-digit RevPAR growth guidance would miss. International is 30% of mix now (vs prior 50%); full recovery required for mid-to-high teens EBITDA growth. If intl stays +1% to +5% YoY, total RevPAR growth drops to mid-single-digits.
Development pipeline delays (Srinagar, Bandhavgarh, Ranthambore, Agra, Ayodhya)
Medium1,000+ key expansion underpins FY30 ₹2,000 Cr EBITDA target. Ranthambore already delayed 2Q (fortress wall stabilization). Further slippage pushes revenue ramp into FY31, risking target credibility.
Dubai JV occupancy/ADR stay depressed (multi-quarter headwind if conflict escalates)
Medium₹156 Cr loss in Q1; loss could recur in Q2–Q3 if West Asia situation worsens. Leela takeover in CY27 will eventually resolve it, but near-term drag on consolidated PAT.
Occupancy growth saturates; ADR growth decelerates
MediumCity hotels at 72% (targeting 75%, not >80%). If occupancy plateaus and domestic leisure ADR softens (macro slowdown), RevPAR growth capped at low single-digits.
Leverage constraint if growth disappoints (FY27–28 EBITDA growth <mid-teens)
Low–MediumCurrent 1.6x Net Debt/EBITDA comfortable. But if FY27 EBITDA growth misses (intl stays weak, occupancy flat), 2.5x ceiling becomes binding and limits capex flexibility for pipeline.
What to watch next
1 · BRICS summit (Sep 12–13, Delhi)
20% of Palace Hotel keys are in Delhi. Q1 saw rate-ups and compression during the AI summit (comparable event). Management expects pre/post demand but will not disclose specifics. If BRICS delivers materially higher rates or occupancy vs. baseline, it is proof-of-concept that events drive pricing power. Watch Delhi occupancy and ADR reported in Q2.
2 · International bookings progression (Jul–Sep leading to peak Oct–Mar season)
Management said July was strong, Aug festive. The real test is whether Sep–Oct forward bookings show international demand returning to 50-50 mix. Monthly international room revenue progression (currently +1% in June) will confirm or refute peak-season normalization. If it reaches +10% to +15% YoY by Sep–Oct, FY27 double-digit RevPAR is on track. If <+5%, guidance is at risk.
3 · Development capex execution (Srinagar, Bandhavgarh Q4 CY27; Agra, Ayodhya CY28)
FY30 ₹2,000 Cr EBITDA target depends on 1,000+ key additions on schedule. Ranthambore's 2Q delay (fortress wall) signals execution risk. Watch capex spend and timeline updates in Q2 call. Further delays weaken FY30 target credibility.
The honest read
Leela delivered a strong operational quarter. The ₹156 Cr Dubai JV loss masks nearly ₹205 Cr in core operating profit. Revenue growth (28%), EBITDA growth (41%), margin expansion (383 bps), and occupancy recovery (+4pp) are all genuine. Management execution has been world-class, and the domestic demand shift is structural.
The stock's +4.73% post-result rally was justified. But the real question—the one that will determine whether FY27 guidance holds and the ₹2,000 Cr FY30 target remains credible—is international demand recovery. A +1% YoY trend in June is not a failure, but it is not a vindication either. Oct–Mar peak season will tell. If international room revenue reaches +10% to +15% YoY in the coming months, the bull case is intact. If it stalls <+5%, the company's ability to deliver double-digit RevPAR and mid-to-high teens EBITDA growth for the full year is compromised.
This is steady, high-quality execution with an external dependency. The number to track from here is monthly international room revenue YoY growth. It is the hinge on which both FY27 delivery and the long-term story turn.
Informational and educational content only. Not investment advice.